Kingsbury Capital Investment Advisors LLC

Position in INTS — Intensity Therapeutics, Inc.

CIK 1927315 Evanston, IL

Position in INTS

as of Jun 30, 2026 · filed Aug 25, 2026 Compact

Position Value

$2,035,621

+$1,811,864 QoQ

Shares Held

496,493

+1204.7% QoQ

Ownership

15.2%

of shares outstanding

% of Portfolio

2.29%

of 13F equity value

Holder Rank

of 17 holders

Holding Since

Mar 2026

2 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Kingsbury Capital Investment Advisors LLC holds $3,647,895 across 3 Biotechnology names. INTS ranks #1 (55.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INTS	Intensity Therapeutics, Inc. This page	496,493	$2,035,621
2	ALZN	Alzamend Neuro, Inc.	1,329,100	$1,594,920
3	CHRS	Coherus Oncology, Inc.	12,396	$17,354

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,035,621	496,493	+1204.7%	Shares	Sole	2026-08-25
2026-03-31	$223,757	38,054	—	Shares	Sole	2026-08-25
No filing history on record for this holder in this stock.